Market Overview:
The global neuroprotective agents market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cerebrovascular diseases, neurodegenerative disorders, ophthalmic diseases, and traumatic CNS injuries. In addition, the increasing demand for novel neuroprotective agents is also contributing to the growth of this market. The global neuroprotective agents market is segmented by type into cerebrovascular diseases, neurodegenerative disorders, ophthalmic diseases, and traumatic CNS injuries. The cerebrovascular disease segment accounted for the largest share of the global Neuroprotective Agents Market in 2017 and is projected to grow at a CAGR of 7% during the forecast period. This can be attributed to rising incidence rates of stroke and other cerebrovascular conditions across the globe. The global Neuroprotective Agents Market is further segmented by application into hospitals, clinics, and others (including research institutes).
Product Definition:
Neuroprotective agents are chemicals that protect the brain from damage. They are important because they can help prevent or slow down neurodegenerative diseases like Alzheimer's and Parkinson's.
Cerebrovascular Diseases:
Cerebrovascular diseases (CVD) is a group of disorders affecting the brain, blood vessels and their surrounding structures. CVDs are one of the leading causes of death worldwide. According to WHO, globally stroke and ischemic heart disease contribute to nearly three-quarters (74%)of all cerebrovascular deaths.
Neurodegenerative Disorders:
Neurodegenerative disorders are a group of conditions that damage the nervous system and cause progressive loss of brain tissue. Neurodegenerative disorders include multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, epilepsy and stroke. The neurodegenerative disorder market is expected to witness lucrative growth over the forecast period owing to increasing prevalence rates coupled with rising awareness levels about these diseases among general population across the globe.
Application Insights:
Based on application, the global neuroprotective agents market is segmented into hospitals, clinics and other medical facilities, and others. Hospitals held the largest share in 2017 owing to a large number of traumatic brain injuries (TBIs) that occur due to road accidents or falls. According to WHO, globally around 250,000-500,000 people suffer from TBI every year and more than half of them are treated in hospital settings. Thus growing incidence of TBIs is expected to contribute towards high demand for neuroprotective agents during the forecast period.
The others segment includes care centers and residential rehabilitation facilities for patients with neurological disorders or spinal cord injuries who require long-term care after discharge from hospitalization or surgery room respectively.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors contributing to its growth. In addition, growing awareness about neuroprotective agents and supportive government initiatives are expected to drive this region’s growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure in emerging countries such as China and India. Moreover, an increase in road accidents is also one of the major causes for concern for this region as it results into a large number of fatalities every year which will boost product demand further on account of rising incidence rates associated with road accidents globally (approximately 1 million deaths per year). These aforementioned factors along with others are expected to contribute towards Asia Pacific’s rapid growth over the next eight years.
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is increasing at an alarming rate. This is mainly due to the changing lifestyle and environmental factors. This is expected to drive the demand for neuroprotective agents in the coming years.
- Growing awareness about neuroprotection: There is a growing awareness among people about the importance of neuroprotection and its role in preventing various neurological diseases. This is likely to boost the demand for neuroprotective agents in the near future.
- Technological advancements: The field of neuroscience has witnessed rapid advancements in recent years, thanks to technological innovations such as CRISPR/Cas9 gene editing technology and 3D printing technology etc. This is likely to fuel the growth of Neuroprotective Agents market in upcoming years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuroprotective Agents Market Research Report
By Type
Cerebrovascular Diseases, Neurodegenerative Disorders, Ophthalmic Diseases, Traumatic CNS Injuries
By Application
Hospitals, Clinics, Others
By Companies
Genervon Biopharmaceuticals, NeuroVive Pharmaceutical, Ceregene, Neuren Pharmaceuticals, Allon Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Neuroprotective Agents Market Report Segments:
The global Neuroprotective Agents market is segmented on the basis of:
Types
Cerebrovascular Diseases, Neurodegenerative Disorders, Ophthalmic Diseases, Traumatic CNS Injuries
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Genervon Biopharmaceuticals
- NeuroVive Pharmaceutical
- Ceregene
- Neuren Pharmaceuticals
- Allon Therapeutics
Highlights of The Neuroprotective Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cerebrovascular Diseases
- Neurodegenerative Disorders
- Ophthalmic Diseases
- Traumatic CNS Injuries
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuroprotective Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neuroprotective agents are medications or supplements that protect the brain from damage. Some of these agents may help to improve memory and cognitive function, reduce inflammation, and improve nerve cell communication.
Some of the major players in the neuroprotective agents market are Genervon Biopharmaceuticals, NeuroVive Pharmaceutical, Ceregene, Neuren Pharmaceuticals, Allon Therapeutics.
The neuroprotective agents market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neuroprotective Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neuroprotective Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neuroprotective Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neuroprotective Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neuroprotective Agents Market Size & Forecast, 2020-2028
4.5.1 Neuroprotective Agents Market Size and Y-o-Y Growth
4.5.2 Neuroprotective Agents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cerebrovascular Diseases
5.2.2 Neurodegenerative Disorders
5.2.3 Ophthalmic Diseases
5.2.4 Traumatic CNS Injuries
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neuroprotective Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neuroprotective Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cerebrovascular Diseases
9.6.2 Neurodegenerative Disorders
9.6.3 Ophthalmic Diseases
9.6.4 Traumatic CNS Injuries
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cerebrovascular Diseases
10.6.2 Neurodegenerative Disorders
10.6.3 Ophthalmic Diseases
10.6.4 Traumatic CNS Injuries
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cerebrovascular Diseases
11.6.2 Neurodegenerative Disorders
11.6.3 Ophthalmic Diseases
11.6.4 Traumatic CNS Injuries
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cerebrovascular Diseases
12.6.2 Neurodegenerative Disorders
12.6.3 Ophthalmic Diseases
12.6.4 Traumatic CNS Injuries
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cerebrovascular Diseases
13.6.2 Neurodegenerative Disorders
13.6.3 Ophthalmic Diseases
13.6.4 Traumatic CNS Injuries
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neuroprotective Agents Market: Competitive Dashboard
14.2 Global Neuroprotective Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Genervon Biopharmaceuticals
14.3.2 NeuroVive Pharmaceutical
14.3.3 Ceregene
14.3.4 Neuren Pharmaceuticals
14.3.5 Allon Therapeutics
